Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and losartan potassium

3,4-dihydroxyphenylacetic acid has been researched along with losartan potassium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akano, EO; Dhanushkodi, A; Matta, SG; McDonald, MP; Rao, SK; Rex, TS; Roguski, EE; Xue, Y1
Han, F; Le, L; Li, P; Ma, X; Su, Y; Yu, H; Zhao, X; Zheng, QY; Zheng, T1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and losartan potassium

ArticleYear
A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism.
    Genes, brain, and behavior, 2013, Volume: 12, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dependovirus; Dopamine; Erythropoietin; Genetic Therapy; Genetic Vectors; Hypokinesia; Injections, Intramuscular; Locomotion; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Mutation, Missense; Neurons; Substantia Nigra; Tremor

2013
Otoprotective effects of erythropoietin on Cdh23erl/erl mice.
    Neuroscience, 2013, May-01, Volume: 237

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acoustic Stimulation; Analysis of Variance; Animals; Auditory Threshold; Cadherins; Cell Count; Chi-Square Distribution; Cochlea; Disease Models, Animal; Erythropoietin; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory; Hearing Loss, Sensorineural; Mice; Mice, Transgenic; Mutation; Otoacoustic Emissions, Spontaneous; Time Factors

2013